Se connecter

Bibliographies thématiques / Non-Alcoholic fatty liver diseases / Livres

Livres sur le sujet « Non-Alcoholic fatty liver diseases »

Pour voir les autres types de publications sur ce sujet consultez le lien suivant : Non-Alcoholic fatty liver diseases.

Auteur : Grafiati

Publié le 22 juin 2023

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 44 meilleurs livres pour votre recherche sur le sujet « Non-Alcoholic fatty liver diseases ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les livres sur diverses disciplines et organisez correctement votre bibliographie.

1

Bugianesi, Elisabetta, dir. Non-Alcoholic Fatty Liver Disease. Cham : Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-95828-6.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

2

Farrell, Geoffrey C., Arthur J. McCullough et Christopher P. Day, dir. Non-Alcoholic Fatty Liver Disease. Oxford, UK : Wiley-Blackwell, 2013. http://dx.doi.org/10.1002/9781118556153.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

3

Chalasani, Naga, et Gyongyi Szabo, dir. Alcoholic and Non-Alcoholic Fatty Liver Disease. Cham : Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20538-0.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

4

Taylor-Robinson, Simon D., et Roger Williams. Clinical dilemmas in non-alcoholic fatty liver disease. Chichester, West Sussex : John Wiley & Sons Inc., 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

5

Farrell, Geoffrey C., Arthur J. McCullough et Christopher Paul Day. Non-alcoholic fatty liver disease : A practical guide. Chichester, West Sussex : John Wiley & Sons, 2013.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

6

Williams, Roger, et Simon D. Taylor-Robinson, dir. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease. Chichester, UK : John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118924938.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

7

Buko, V. U. Prostaglandiny pri alkogolʹnom porazhenii pecheni. Minsk : "Navuka i tėkhnika", 1991.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

8

Fitzpatrick, Emer. Non-alcoholic fatty liver disease. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198759928.003.0061.

Texte intégral

Résumé :

The chapter on non-alcoholic fatty liver disease includes the risk factors for this ever-increasing condition, the pathophysiology, as well as the differential of hepatic steatosis. Finally it includes the most current principles of its management.

Styles APA, Harvard, Vancouver, ISO, etc.

9

Khanna, Sudeep. Non-Alcoholic Fatty Liver Disease. Elsevier - Health Sciences Division, 2010.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

10

Chalasani, Naga, et Gyongyi Szabo. Alcoholic and Non-Alcoholic Fatty Liver Disease : Bench to Bedside. Springer, 2015.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

11

Chalasani, Naga, et Gyongyi Szabo. Alcoholic and Non-Alcoholic Fatty Liver Disease : Bench to Bedside. Springer London, Limited, 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

12

Chalasani, Naga, et Gyongyi Szabo. Alcoholic and Non-Alcoholic Fatty Liver Disease : Bench to Bedside. Springer, 2019.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

13

undifferentiated, Roger Williams, et Simon D. Taylor-Robinson. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease. Wiley & Sons, Limited, John, 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

14

undifferentiated, Roger Williams, et Simon D. Taylor-Robinson. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease. Wiley & Sons, Incorporated, John, 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

15

undifferentiated, Roger Williams, et Simon D. Taylor-Robinson. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease. Wiley & Sons, Incorporated, John, 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

16

Day, Christopher P., Geoffrey C. Farrell et Arthur J. McCullough. Non-Alcoholic Fatty Liver Disease : A Practical Guide. Wiley & Sons, Incorporated, John, 2013.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

17

Day, Christopher P., Geoffrey C. Farrell et Arthur J. McCullough. Non-Alcoholic Fatty Liver Disease : A Practical Guide. Wiley & Sons, Incorporated, John, 2013.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

18

Day, Christopher P., Geoffrey C. Farrell et Arthur J. McCullough. Non-Alcoholic Fatty Liver Disease : A Practical Guide. Wiley & Sons, Incorporated, John, 2013.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

19

Day, Christopher P., Geoffrey C. Farrell et Arthur J. McCullough. Non-Alcoholic Fatty Liver Disease : A Practical Guide. Wiley & Sons, Limited, John, 2013.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

20

Pearce, Pearson. Non-Alcoholic Fatty Liver Disease : All You Must Know about Non-Alcoholic Fatty Liver Disease. Independently Published, 2021.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

21

Non-Alcoholic Fatty Liver Disease Research 2016. MDPI, 2018. http://dx.doi.org/10.3390/books978-3-03897-601-1.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

22

OGAGAOGHENE, Isreal. Non Alcoholic Fatty Liver Disease : All You Must Know. Independently Published, 2020.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

23

Bugianesi, Elisabetta. Non-Alcoholic Fatty Liver Disease : A 360-degree Overview. Springer, 2020.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

24

Gaglio, Paul J. Non-Alcoholic Fatty Liver Disease, an Issue of Clinics in Liver Disease. Elsevier, 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

25

Gaglio, Paul J. Non-Alcoholic Fatty Liver Disease, an Issue of Clinics in Liver Disease. Elsevier - Health Sciences Division, 2016.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

26

Beattie, R. Mark, Anil Dhawan et John W.L. Puntis. Fatty liver disease in children. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780198569862.003.0055.

Texte intégral

Résumé :

Demographics 406Pathophysiology 406Differential diagnoses 407Presenting features 407Investigation 408Management 409Fatty liver disease is now increasingly recognized in children, particularly in the setting of obesity.The term non-alcoholic steatohepatitis (NASH) was first coined in 1980 by Ludwig to describe a pattern of liver injury in adults in which the liver histology was consistent with alcoholic hepatitis, but in whom significant alcohol consumption was denied. NASH can be considered as part of a broader spectrum of non-alcoholic fatty liver disease that extends from simple steatosis through steatohepatitis that is characterized by the potential to progress to fibrosis, cirrhosis and subsequent end stage liver disease....

Styles APA, Harvard, Vancouver, ISO, etc.

27

Valenzuela, Rodrigo, dir. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment. InTech, 2018. http://dx.doi.org/10.5772/68045.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

28

Keshav, Satish, et Palak Trivedi. Miscellaneous liver diseases. Sous la direction de Patrick Davey et David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0216.

Texte intégral

Résumé :

This chapter discusses miscellaneous liver diseases, including non-alcoholic fatty liver disease, liver abscess, and nodular regenerative hyperplasia. It explores definitions of the diseases, their etiologies, typical symptoms, uncommon symptoms, demographics, natural history, complications, diagnostic approach, other diagnoses that should be considered, prognosis, and treatment.

Styles APA, Harvard, Vancouver, ISO, etc.

29

Keshav, Satish, et Alexandra Kent. Alcoholic liver disease. Sous la direction de Patrick Davey et David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0211.

Texte intégral

Résumé :

Alcoholic liver disease develops in excessive drinkers and can manifest in three forms: alcoholic fatty liver (steatosis; >80%), alcoholic hepatitis (10%–35%), and cirrhosis (10%). The more alcohol consumed, the greater the risk of alcoholic liver disease, although other factors may also be involved. Alcohol can cause significant damage without producing any symptoms, and many patients will only have liver dysfunction detected on routine blood tests. Many patients report non-specific symptoms, such as anorexia, morning nausea, diarrhoea, and vague right upper quadrant abdominal pain. The underlying pathogenesis of alcohol-induced injury is not fully understood but is thought to involve various mechanisms. This chapter discusses alcoholic liver disease, focusing on its etiology, symptoms, demographics, natural history, complications, diagnosis, prognosis, and treatment.

Styles APA, Harvard, Vancouver, ISO, etc.

30

McNiff, Pil, et Diana Jo Rossano. Non Alcoholic Fatty Liver Disease : Recipes That Improve NASH, NAFLD, and Silent Liver Disease. Independently Published, 2019.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

31

Bergheim, Ina, et Jörn M. Schattenberg. Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease. Mdpi AG, 2019.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

32

Avand, Ghazal. Metabolic syndrome in non-alcoholic fatty liver disease : A comparison between simple steatosis and non-alcoholic steatohepatitis. 2006.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

33

Nutritional Intake and the Risk for Non-alcoholic Fatty Liver Disease (NAFLD). MDPI, 2019. http://dx.doi.org/10.3390/books978-3-03897-599-1.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

34

Non-alcoholic Fatty Liver Disease - New-Insight and Glance Into Disease Pathogenesis [Working Title]. IntechOpen, 2023. http://dx.doi.org/10.5772/intechopen.100998.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

35

Mohammed, Saira Saddia. Obesity is not associated with non-alcoholic fatty liver disease (NAFLD) in HIV-positive gay males. 2006.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

36

Mancell, Sara, et Deepa Kamat. Nutritional management of liver disease. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198759928.003.0068.

Texte intégral

Résumé :

The chapter on nutrition and liver disease describes the pathophysiology of the malnutrition that frequently accompanies chronic liver disease in children and then discusses the suggested management as well as ways of nutritional assessment and monitoring of the children. There is also a section of specific suggestions for various conditions such as biliary atresia, Alagille syndrome, Wilson disease, non-alcoholic fatty liver disease, as well as an overview of the various special feeds and supplements used in these conditions.

Styles APA, Harvard, Vancouver, ISO, etc.

37

Carton, James. Hepatobiliary pathology. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198759584.003.0008.

Texte intégral

Résumé :

This chapter discusses hepatobiliary pathology and covers acute viral hepatitis, chronic viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), Wilson’s disease, hereditary haemochromatosis, cirrhosis, benign liver lesions, hepatocellular carcinoma (liver cell cancer), intrahepatic cholangiocarcinoma, cholecystitis, and extrahepatic bile duct carcinoma.

Styles APA, Harvard, Vancouver, ISO, etc.

38

Jolly, Elaine, Andrew Fry et Afzal Chaudhry, dir. Gastroenterology and hepatology. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199230457.003.0009.

Texte intégral

Résumé :

Chapter 9 covers the basic science and clinical topics relating to gastroenterology and hepatology which trainees are required to learn as part of their basic training and demonstrate in the MRCP. It covers basic science, gastrointestinal investigation, malabsorption and malnutrition, inflammatory bowel disease, acute upper gastrointestinal haemorrhage, lower gastrointestinal bleeding and related disorders, gastrointestinal infections, gastrointestinal cancer, miscellaneous gastrointestinal problems, normal liver and biliary function, variceal disease, hepatic tumours, acute (fulminant) liver failure, haemochromatosis, Wilson disease (hepatolenticular degeneration), Alpha-1 antitrypsin deficiency, alcohol-induced liver disease, hepatitis, biliary diseases, and non-alcoholic fatty liver disease.

Styles APA, Harvard, Vancouver, ISO, etc.

39

Keshav, Satish, et Alexandra Kent. Prevention of gastrointestinal disease. Sous la direction de Patrick Davey et David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0346.

Texte intégral

Résumé :

Disease prevention is usually directed where there is considerable morbidity or mortality, and etiological factors that can be controlled, treated, or reduced. The greatest morbidity and mortality from gastrointestinal disease is related to infectious diarrhoea and gastrointestinal cancer, both of which can be prevented. Smoking has been closely associated with oesophageal, gastric, and liver cancer and also has a significant effect in inflammatory bowel disease. In addition, alcohol consumption and viral hepatitis are preventable causes of liver disease, liver failure, and hepatic cancer. This chapter addresses the prevention of gastrointestinal disease, focusing on alcohol, smoking, peptic ulcer disease, colorectal cancer, oesophageal adenocarcinoma, hepatitis B, hepatitis C, non-alcoholic fatty liver disease, and gastrointestinal infection.

Styles APA, Harvard, Vancouver, ISO, etc.

40

CHRIS, John. Fatty Liver Rescue : Comprehensive Cure of Non-Alcoholic Fatty Liver for Beginners. Independently Published, 2020.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

41

Plebani, Mario, Monica Maria Mion et Martina Zaninotto. Biomarkers of renal and hepatic failure. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0039.

Texte intégral

Résumé :

In the last few years, major advances have been achieved in the understanding of the molecular and pathophysiological mechanisms which underlie the complex interactions between the heart and the kidney, as well as between the heart and the liver. According to these new insights, new biomarkers have been proposed for better evaluating and monitoring patients affected by cardiovascular diseases. In addition, some biomarkers should be used as risk factors and for an early identification and treatment of these severe diseases. This chapter reviews the most important biomarkers for evaluating the ‘cardiorenal syndrome’, in particular, the measurement of serum creatinine and its use for calculating the glomerular filtration rate which, with the new and more efficient equation, namely Chronic Kidney Disease Epidemiology Collaboration, still remains the most widely used biomarker. The role of newer biomarkers will be explored. The measurement of cystatin C, representing additional information, particularly in paediatric age groups and in the early phase of kidney disease, plays an increasing role. Neutrophil gelatinase-associated lipocalin is a recently developed and very promising new biomarker for the diagnosis of acute kidney injury, while the well-known albumin/creatinine ratio has been re-evaluated as a simple and useful tool for an early identification of kidney disease. Regarding liver diseases, a growing body of evidence demonstrates the usefulness of non-invasive makers of hepatic fibrosis that may avoid the need for a liver biopsy in most patients. A promising field of research is represented by the role of non-alcoholic fatty liver disease in the pathogenesis of cardiovascular disease.

Styles APA, Harvard, Vancouver, ISO, etc.

42

Carton, James. Hepatobiliary pathology. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199591633.003.0007.

Texte intégral

Résumé :

Acute viral hepatitis 116Chronic viral hepatitis 117Alcoholic liver disease 118Non-alcoholic fatty liver disease 119Autoimmune hepatitis 120Primary biliary cirrhosis 121Primary sclerosing cholangitis 122Wilson's disease 123Hereditary haemochromatosis 124Cirrhosis 125Benign liver lesions 126Hepatocellular carcinoma 127Intrahepatic cholangiocarcinoma ...

Styles APA, Harvard, Vancouver, ISO, etc.

43

Harrison, Stephen A. Non-Alcoholic Steatohepatitis, an Issue of Clinics in Liver Disease. Elsevier - Health Sciences Division, 2009.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

44

Levy, Barry S. Liver Disorders. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190662677.003.0030.

Texte intégral

Résumé :

This chapter describes occupational and environmental liver disorders. It describes the types of liver function and types of liver damage, and how these functions and this damage can be assessed. Workers in healthcare and solid waste management are at increased risk hepatitis B virus and hepatitis C virus infections. Occupational exposure to swine is associated with hepatitis E virus infection. More than 100 industrial chemicals can be acutely hepatotoxic in experimental animals or humans. Metabolic reactions may affect the hepatotoxicity of chemicals. Occupational exposure to organic solvents can cause toxic hepatitis. Occupational exposure to vinyl chloride monomer has been causally associated with toxicant-associated fatty liver disease as well as a form of non-cirrhotic portal hypertension. Several agents can cause cancer of the liver or bile ducts. Vinyl chloride monomer is causally associated with angiosacoma of the liver. Arsenic causes liver cancer. Dietary exposure to aflatoxins can cause hepatoceulluar carcinoma.

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!